Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

132.59 +6.37 (+5.04%)
Streaming Delayed Price Updated: 10:48 AM EDT, Apr 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings
Via Benzinga
Abbott Stock Rises On Strong Q1 Earnings: Retail’s In Wait-And-Watch Mode
Abbott reaffirmed its full-year 2025 financial guidance and expects full-year 2025 adjusted diluted earnings per share of $5.05 to $5.25. 
Via Stocktwits
Topics Government
Exposures Political
Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty
Abbott reaffirmed its 2025 EPS guidance supported by strong Diabetes and Nutrition growth. 
Via Benzinga
Abbott Laboratories Dips As Sales Come In Light Despite Profit Beat
Abbott stock slipped early Wednesday after the health giant reported light first-quarter sales, though profit beat views. 
Via Investor's Business Daily
Abbott Laboratories (NYSE:ABT) Posts Q1 Sales In Line With Estimates
Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 4% year on year to $10.36 billion. Its non-GAAP profit of $1.09... 
Via StockStory
Abbott Laboratories's Earnings Outlook
Via Benzinga
Abbott Laboratories Reports Strong First Quarter Results, Maintains Positive Outlook
Abbott Laboratories reported a strong start to 2025 with significant growth in sales and EPS, exceeding market expectations. 
Via Talk Markets
Topics Stocks / Equities
US Stock Likely To Open Lower As US-China Tariff War Continues: 'Valuations Are Now Looking More Compelling,' Says Expert
U.S. stock futures declined on Wednesday following a muted day of trading on Tuesday. Futures of indices were lower in premarket. 
Via Benzinga
Earnings Scheduled For April 16, 2025
Via Benzinga
Dow Falls Over 150 Points Even As Citi, Bank Of America Earnings Beat Expectations: Greed Index Remains In 'Extreme Fear' Zone
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Abbott Laboratories, Travelers Companies And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
This House of Representative Just Bought Up To $390K In Abbott Laboratories Stock
Via Benzinga
How To Earn $500 A Month From Abbott Laboratories Stock Ahead Of Q1 Earnings
Abbott Laboratories offers a quarterly dividend amount of 59 cents per share ($2.36 a year). Here's how investors can pocket $500 monthly. 
Via Benzinga
Abbott Laboratories (ABT) Q1 Earnings: What To Expect
Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results tomorrow before the bell. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Recent Filing Shows That Rep. Josh Gottheimer Sold Over $32K Worth of Abbott Laboratories Stock
Via Benzinga
Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device
Dexcom stock surged Thursday after the FDA cleared its newest diabetes device for an extended 15-day wear time. 
Via Investor's Business Daily
Topics Government Stocks World Trade
Exposures Political Product Safety Tariff
President Trump's Tariffs Have Arrived. 3 Things to Do to Protect Your Portfolio.
Via The Motley Fool
Topics Economy Government Stocks
Exposures Economy Political Tariff
Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks
Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season. 
Via StockStory
2 Value Stocks I'm Buying Right Now
Via The Motley Fool
Topics Economy
Exposures Interest Rates
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
Via The Motley Fool
Topics Intellectual Property Retirement
Exposures Intellectual Property Pension
3 Relatively Safe Stocks to Buy Right Now
Via The Motley Fool
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too?
Via The Motley Fool
Topics ETFs Economy Government
Exposures Economy Political Tariff
Why Abbott Laboratories Stock Leaped by Almost 4% on Thursday
Via The Motley Fool
Which S&P500 stocks are moving on Thursday?
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session. 
Via Chartmill
What's going on in today's session: S&P500 movers
Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
From Rookie Mistakes To $10K/Year In Dividends – Military Veteran Who 'Made A Few Great Plays' Shares His 10 Biggest Bets
Via Benzinga
2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income
Via The Motley Fool
What Does the Market Think About Abbott Laboratories?
Via Benzinga
Decoding Abbott Laboratories's Options Activity: What's the Big Picture?
Via Benzinga
No Quick Fix For This Market
Despite the pullback, we have found numerous opportunities which we discuss in this video using technical analysis. 
Via Talk Markets
Topics Stocks / Equities
< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.